Best in Class Erectile Dysfunction Drug – DRGT Announces Dose Escalation Study Results of Its Super-Tadalafil DRGT-99

MALTA, May 2 (Korea Bizwire) — DRGT, a specialty pharmaceutical company with a proprietary formulation technology, announced the results of its successful dose escalation PK study for DRGT-99, an innovative formulation of tadalafil.  Tadalafil (Cialis®) was originally developed by Lilly ICOS, LLC –a longer lasting alternative to Sildenafil Citrate (Viagra®) and is indicated for the [...]